Funda Şimşek

453 total citations
38 papers, 201 citations indexed

About

Funda Şimşek is a scholar working on Infectious Diseases, Oncology and Epidemiology. According to data from OpenAlex, Funda Şimşek has authored 38 papers receiving a total of 201 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Infectious Diseases, 12 papers in Oncology and 10 papers in Epidemiology. Recurrent topics in Funda Şimşek's work include Neutropenia and Cancer Infections (9 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Antifungal resistance and susceptibility (5 papers). Funda Şimşek is often cited by papers focused on Neutropenia and Cancer Infections (9 papers), Bacterial Identification and Susceptibility Testing (7 papers) and Antifungal resistance and susceptibility (5 papers). Funda Şimşek collaborates with scholars based in Türkiye, Antigua and Barbuda and Russia. Funda Şimşek's co-authors include Taner Yıldırmak, Habip Gedık, Demet Aydın, Murat Ersöz, Mine Adaş, Mutlu Arat, Hakan Sezgin Sayıner, Kadriye Kart Yaşar, Seçil Arıca and Yaşar Ali Öner and has published in prestigious journals such as International Journal of Infectious Diseases, American Journal of Infection Control and Journal of Clinical Virology.

In The Last Decade

Funda Şimşek

32 papers receiving 192 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Funda Şimşek Türkiye 7 74 74 62 60 41 38 201
Angeliki M. Andrianaki Greece 8 94 1.3× 119 1.6× 75 1.2× 51 0.8× 55 1.3× 12 243
Linda Graviss United States 9 116 1.6× 103 1.4× 54 0.9× 64 1.1× 65 1.6× 14 305
Sonia Isabel Cuervo Colombia 10 99 1.3× 86 1.2× 45 0.7× 56 0.9× 57 1.4× 47 253
Tim Götting Germany 6 56 0.8× 79 1.1× 44 0.7× 78 1.3× 59 1.4× 9 194
Zümrüt Şahbudak Bal Türkiye 8 103 1.4× 102 1.4× 41 0.7× 36 0.6× 22 0.5× 56 231
Jeong Eun Lee South Korea 9 84 1.1× 75 1.0× 54 0.9× 23 0.4× 18 0.4× 31 209
Fernanda Spadão Brazil 10 51 0.7× 130 1.8× 130 2.1× 48 0.8× 29 0.7× 16 262
Yoon Hee Jun South Korea 8 64 0.9× 129 1.7× 75 1.2× 29 0.5× 29 0.7× 15 304
Maryann Shango United States 6 53 0.7× 98 1.3× 134 2.2× 30 0.5× 71 1.7× 9 296
Orna Schwartz Israel 8 84 1.1× 55 0.7× 34 0.5× 28 0.5× 32 0.8× 21 175

Countries citing papers authored by Funda Şimşek

Since Specialization
Citations

This map shows the geographic impact of Funda Şimşek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Funda Şimşek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Funda Şimşek more than expected).

Fields of papers citing papers by Funda Şimşek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Funda Şimşek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Funda Şimşek. The network helps show where Funda Şimşek may publish in the future.

Co-authorship network of co-authors of Funda Şimşek

This figure shows the co-authorship network connecting the top 25 collaborators of Funda Şimşek. A scholar is included among the top collaborators of Funda Şimşek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Funda Şimşek. Funda Şimşek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Şimşek, Funda, et al.. (2022). COVID-19 Pneumonia: Variation of Chest Computed Tomographic Findings at Different Phases of Disease. 38(1). 61–66. 1 indexed citations
3.
4.
Şimşek, Funda, et al.. (2022). Monkeypox Virus Infection: First Two Cases in Turkey. Klimik Dergisi/Klimik Journal. 35(4). 267–270. 1 indexed citations
5.
Şimşek, Funda, et al.. (2021). Prediction of Clinical Results with the First Thoracic CT Findings in COVID-2019 Patients; Survey Study. 37(4). 268–272. 1 indexed citations
6.
Arıca, Seçil, et al.. (2021). COVID-19 Vaccines. 37(3). 134–140. 2 indexed citations
7.
8.
Şimşek, Funda, et al.. (2020). The effect of stigmatization on quality of life in male patients with HIV/AIDS. Anatolian Journal of Psychiatry. 21(0). 1–1.
9.
Yıldırmak, Taner, et al.. (2016). Could Neutrophil CD64 Expression Be Used as a Diagnostic Parameter of Bacteremia in Patients with Febrile Neutropenia?. Turkish Journal of Hematology. 34(2). 167–173. 5 indexed citations
10.
Gedık, Habip, et al.. (2014). Novel Antifungal Drugs Against Fungal Pathogens: Do They Provide Promising Results for Treatment?. Indian Journal of Hematology and Blood Transfusion. 31(2). 196–205. 4 indexed citations
11.
Gedık, Habip, et al.. (2014). Community-acquired intracranial suppurative infections: A 15-year report. Surgical Neurology International. 5(1). 142–142. 9 indexed citations
12.
Gedık, Habip, et al.. (2014). Primary or secondary antifungal prophylaxis in patients with hematological maligancies: efficacy and damage. Therapeutics and Clinical Risk Management. 10. 305–305. 6 indexed citations
13.
Yıldırmak, Taner, et al.. (2014). Community-acquired intracranial suppurative infections: 15-year report. 5. 3 indexed citations
14.
Gedık, Habip, et al.. (2013). The outcome of non-carbapenem-based empirical antibacterial therapy and VRE colonisation in patients with hematological malignancies. African Health Sciences. 13(2). 362–8. 7 indexed citations
15.
Gedık, Habip, et al.. (2013). Fungal pathogens and primary antifungal prophylaxis in patients with hematological malignancies: one year experience. African Health Sciences. 12(3). 390–4. 4 indexed citations
16.
Gedık, Habip, et al.. (2013). When and which fungal pathogens should come to mind in patients with hematological malignancies. 1 indexed citations
17.
Hakyemez, İ̇smail Necati, et al.. (2012). Akut Hepatitli 596 Erişkin Olgunun Retrospektif Değerlendirilmesi. Viral Hepatitis Journal. 18(3). 87–90.
18.
Sayıner, Hakan Sezgin, et al.. (2012). Vancomycin-resistant Enterococcus carrier status in the reanimation units and related risk factors. American Journal of Infection Control. 41(3). 261–262. 7 indexed citations
19.
Şimşek, Funda, et al.. (2012). Colistin against colistin-only-susceptible Acinetobacter baumannii-related infections: Monotherapy or combination therapy?. Indian Journal of Medical Microbiology. 30(4). 448–452. 37 indexed citations
20.
Şimşek, Funda, et al.. (2002). Distribution of HLA-DQA1 and Amplitype PM Locus Alleles in Aegean Region of Turkey. Journal of Forensic Sciences. 47(3). 671–672. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Angeliki M. Andrianaki Breakdown of academic impact, for papers by Linda Graviss Breakdown of academic impact, for papers by Sonia Isabel Cuervo Breakdown of academic impact, for papers by Tim Götting Breakdown of academic impact, for papers by Zümrüt Şahbudak Bal Breakdown of academic impact, for papers by Jeong Eun Lee Breakdown of academic impact, for papers by Fernanda Spadão Breakdown of academic impact, for papers by Yoon Hee Jun Breakdown of academic impact, for papers by Maryann Shango Breakdown of academic impact, for papers by Orna Schwartz
Rankless by CCL
2026